p53 protein expression and genetic mutation in two primary cell types in pulmonary sclerosing haemangioma
- 17 August 2007
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 61 (2), 192-196
- https://doi.org/10.1136/jcp.2007.050401
Abstract
Aims: To investigate the significance of p53 protein expression and genetic mutations in two primary cell types in pulmonary sclerosing haemangioma (PSH). Methods: p53 protein expression in polygonal cells and cuboidal cells in 19 patients with PSH was detected using immunohistochemistry. The two major cell types were captured using laser capture microdissection technology. Mutations in the p53 gene (exons 5–8) were examined using single-stranded conformation polymorphism and DNA sequencing analysis. Results: p53 protein expression and gene mutations were observed in 15.8% (3/19) of cases. In these cases, p53 protein was expressed in the nucleus of both cell types, with higher expression levels and mutation rates in polygonal cells than in surface cuboidal cells. Two cases showed mutation only in the polygonal cells, while one case showed double (separate) mutations in both the polygonal and cuboidal cells. Conclusions: p53 mutation was exhibited in PSH. The mutation rate in polygonal cells was higher than that in surface cuboidal cells.Keywords
This publication has 16 references indexed in Scilit:
- Expression of E-cadherin, β-catenin and p120ctn in the pulmonary sclerosing hemangiomaLung Cancer, 2007
- Pulmonary Sclerosing Hemangioma with Pulmonary MetastasisThe Thoracic and Cardiovascular Surgeon, 2006
- Pulmonary Sclerosing Hemangioma With Metastasis to the Mediastinal Lymph NodeThe Annals of Thoracic Surgery, 2005
- An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survivalProceedings of the National Academy of Sciences, 2005
- Clinicopathological Analysis of Pulmonary Sclerosing HemangiomaThe Annals of Thoracic Surgery, 2004
- Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lungLung Cancer, 2004
- Immunohistochemical and ultrastructural markers suggest different origins for cuboidal and polygonal cells in pulmonary sclerosing hemangiomaHuman Pathology, 2004
- Prognostic value of p53 mutations, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinomaCancer, 2002
- Sclerosing hemangioma with metastases to multiple nodal stationsThe Annals of Thoracic Surgery, 2002
- Prognostische Bedeutung der Expression von p53, bcl-2 und bax im Plattenepithelkarzinom des Larynx - Eine multivariate AnalyseHNO, 2001